LM-299

• Description:

  LM-299 is a PD-1/VEGF bispecific antibody. LM-299 achieves its dual binding activity through the effective binding of the anti-VEGF-A antibody at the fab end to human VEGF-A, coupled with the blockade of the PD-1/PD-L1 pathway by the anti-PD-1 antibody at the-Fc end. LM-299 can b eused for the study of non-small cell lung cancer (NSCLC) .

• UNSPSC:

  12352005

• Target:

  PD-1/PD-L1; VEGFR

• Related Pathways:

  Immunology/Inflammation; Protein Tyrosine Kinase/RTK

• Field of Research:

  Cancer

• Smiles:

  [LM-299]

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Inhibitory Antibodies

• Clinical Information:

  No Development Reported